Why is Webuy Global stock surging today?

WEBUY GLOBAL LTD (WBUY) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Results of Operations Comparative financial information for the six months ended June 30, 2025 has been retrospectively reclassified to reflect the Singapore grocery business as discontinued operations following its disposal in 2025, consistent with the presentation

Webuy Global Ltd (WBUY) shares rose 22.3% after reporting record preliminary travel bookings of $4.76M at the NATAS Fair, up 42% from March 2026. Bookings were driven by mainstream and premium travel products, with Altitude brand contributing 21%. CEO Bin Xue highlighted customer response to differentiated travel products. The company plans to expand its premium travel portfolio and technology capabilities.

Aardvark Therapeutics (NASDAQ:AARD) shares rose 21% after the FDA lifted its clinical hold on ARD-101, a drug for Prader-Willi Syndrome. The hold was placed in May 2026 after ECG changes were observed. Aardvark conducted additional studies and plans to resume trials. The company will review trial data in a webcast on October 23, 2026.

Shopify (SHOP) shares dropped 3% after ATB Cormark downgraded the stock to Sector Perform with a C$234 price target. The downgrade follows a 56% three-month gain driven by AI shopping partnerships. Analysts expect earnings per share to more than double from fiscal 2025 to 2028, but the stock's high valuation reflects much of this growth.

Moderna (MRNA) fell 17.57% to $202.63 after reports of a data leak on its melanoma vaccine. The S&P 500 and Nasdaq also declined. Investors await full Phase 3 data on Oct. 24. Trading volume was 148% above average. BioNTech (BNTX) and Novavax (NVAX) also dropped.

Zscaler (ZS) shares rose 3% after Freedom Broker raised its price target to $270. Analysts expect revenue to grow from $3.35B in 2026 to $5.33B by 2029. The increase follows AI-discovered flaws in PHP, boosting cybersecurity stocks. DA Davidson maintained a Neutral rating with a $215 target.